Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04602078
Title Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma (AUREA)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Oncology Genito-Urinary Group
Indications

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

Atezolizumab + Cisplatin + Gemcitabine

Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital de la Santa Creu i Sant Pau Barcelona 08041 Spain Details
ICO Hospitalet- Hospital Duran i Reynals Barcelona 08908 Spain Details
Hospital Provincial de Castellón Castellón De La Plana 12002 Spain Details
Hospital Universitario de Jaén Jaén Spain Details
Complejo Hospitalario Universitario Insular Marterno Infantil Las Palmas De Gran Canaria 35016 Spain Details
Hospital Clínico Universitario San Carlos Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario La Paz Madrid 28046 Spain Details
Complejo Hospitalario Universitario Ourense Orense Spain Details
Hospital Universitario Central de Asturias Oviedo 33011 Spain Details
Hospital Son Llàtzer Palma De Mallorca 07198 Spain Details
Hospital Virgen de la Salud Toledo Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field